Sridhar Srinivasan Nambi MD

Diabetes, Lipid Metabolism

endocrine and metabolic lock

225 Millburn Ave104BMillburn, NJ 07041
Phone+1 973-535-8870
Fax+1 973-535-8818

Dr. Nambi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nambi's full profile Already have an account?

Summary

Dr. Sridhar Nambi is an endocrinologist based in Livingston, NJ, with subspecialties in diabetes and lipid metabolism. He completed his fellowship in Endocrinology, Diabetes, and Metabolism at the National Institutes of Health Clinical Center and his residency in Internal Medicine at Cleveland Clinic Foundation/Fairview Hospital. Dr. Nambi is experienced in managing diabetes mellitus, obesity and related disorders, lipid metabolism disorders, and thyroid disease. His contributions to the field include several notable publications, with his work on insulin sensitivity being significantly cited. He has received multiple honors, including CMS Meaningful Use Stage Certifications and recognition as a Fellow of the American Association of Clinical Endocrinology.

Education & Training

National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1999
Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 1993 - 1995
Gandhi Medical CollegeClass of 1984

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NJ State Medical License 1998 - 2027
MD State Medical License 1996 - 1999
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification GlaceEMR, Glenwood Systems LLC, 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification GlaceEMR, Glenwood Systems LLC, 2012, 2014-2017
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

12 citations
Adrenal Crisis Secondary to COVID-19 Vaccination in a Patient With Hypopituitarism.
Nikolina Markovic, Anila Faizan, Chirag Boradia, Sridhar Nambi
AACE Clinical Case Reports. 2022-04-25
20 citations
The V-Go Insulin Delivery Device Used In Clinical Practice: Patient Perception and Retrospective Analysis of Glycemic Control
Cheryl R. Rosenfeld, Nancy J. V. Bohannon, Bruce W. Bode, Adam S. Kelman, Shari N. Mintz
Endocrine Practice. 2012-05-01
2517 citations
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.
Arie Katz, Sridhar S. Nambi, Kieren J. Mather, Alain D. Baron, Dean Follmann
The Journal of Clinical Endocrinology and Metabolism. 2000-07-01